These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7071947)

  • 41. [Problems concerning clinical application of calcitonin].
    Morii H
    Nihon Rinsho; 1972 Mar; 30(3):759-65. PubMed ID: 4556796
    [No Abstract]   [Full Text] [Related]  

  • 42. Thyrotoxicosis and hypercalcaemia: response to antithyroid drugs and salmon calcitonin.
    Woodhouse NJ; Hoare A; Mohamedally SM; Marsden P
    Horm Res; 1976; 7(4-5):238-46. PubMed ID: 65311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paget's disease of the skull and migraine headache.
    Hamilton CR; Quesada O
    Johns Hopkins Med J; 1973 Mar; 132(3):179-85. PubMed ID: 4266199
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute responsiveness to calcitonin in chronic renal failure.
    Cochran M; Hillyard CJ; Dew GJ; Martin TJ
    Br Med J; 1976 Aug; 2(6032):396-8. PubMed ID: 947443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Urine hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in neoplastic diseases].
    Radom S; Zulawski M; Golebiowska D
    Nowotwory; 1971; 21(4):267-73. PubMed ID: 5138713
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum calcitonin in patients with osteolytic and osteosclerotic metastases from mammary carcinoma.
    Nielsen HE; Gadeberg CC
    Acta Radiol Oncol; 1980; 19(5):331-3. PubMed ID: 6259888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
    Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
    Evans RA; Somers NM; Dunstan CR; Hills E; Evans M
    Calcif Tissue Int; 1991 Sep; 49(3):164-7. PubMed ID: 1933580
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment.
    DeRose J; Singer FR; Avramides A; Flores A; Dziadiw R; Baker RK; Wallach S
    Am J Med; 1974 Jun; 56(6):858-66. PubMed ID: 4857531
    [No Abstract]   [Full Text] [Related]  

  • 50. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [State of protein and mineral metabolism following thyrocalcitonin administration during experimental osteogenesis].
    Khomullo GV; Travkina VM; Ryzhova TI; Kokoreva GA
    Vopr Med Khim; 1978; 24(5):613-7. PubMed ID: 706253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH; Avery S; Johnston CC
    J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538
    [No Abstract]   [Full Text] [Related]  

  • 53. Paget's disease. Radiological changes occurring in untreated patients and those on therapy with salmon calcitonin during two years' observation.
    Woodhouse NJ; Chalmers AH; Wells IP; Dewbury KC; Mohamedally SM
    Br J Radiol; 1977 Oct; 50(598):699-705. PubMed ID: 562693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of Paget's disease of bone with porcine calcitonin.
    Eisman JA; Xipell JM; Sloman JG; Jerums G; Martin TJ
    Med J Aust; 1974 Apr; 1(15):564-8. PubMed ID: 4858264
    [No Abstract]   [Full Text] [Related]  

  • 55. Paget disease of bone. Long-term treatment with salmon calcitonin.
    Schuhmacher CA; Scurry MT; Deiss WP
    Arch Intern Med; 1973 May; 131(5):722-4. PubMed ID: 4735644
    [No Abstract]   [Full Text] [Related]  

  • 56. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
    Radom S; Zulawski M; Golebiowska D
    Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.
    Rosenberg E; Lang R; Boisseau V; Rojanasathit S; Avioli LV
    J Clin Endocrinol Metab; 1977 Feb; 44(2):346-55. PubMed ID: 557059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remissions in Paget's disease produced by human synthetic calcitonin (calcitonin M).
    Woodhouse NJ; Reiner M; Kalu DN; Galante L; Joplin GF; MacIntyre I
    Clin Sci; 1970 Sep; 39(3):9P-10P. PubMed ID: 5459177
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
    Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.